Hong Kong Healthcare Services Stock News

Goldman Sachs recently initiated coverage on Keymed Biosciences, highlighting the approval of its first commercial product, stapokibart, in China for atopic dermatitis and chronic rhinosinusitis, while expressing confidence in the pipeline asset CM512 for asthma and COPD. This development underscores the growing recognition of Keymed's product pipeline and the confidence major institutions are placing in the company's future prospects. We'll explore how optimism for Keymed's pipeline,...

Generally speaking long term investing is the way to go. But along the way some stocks are going to perform badly...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...

We think intelligent long term investing is the way to go. But unfortunately, some companies simply don't succeed. To...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

China Coal Energy Company Limited ( HKG:1898 ) shares have had a really impressive month, gaining 26% after a shaky...

MicroPort Scientific Corporation ( HKG:853 ) shares have had a horrible month, losing 26% after a relatively good...

Key Insights The projected fair value for Sinofert Holdings is HK$2.44 based on Dividend Discount Model Current share...

Q Technology (Group) Company Limited ( HKG:1478 ) shares have had a horrible month, losing 25% after a relatively good...

Key Insights The considerable ownership by individual investors in Crypto Flow Technology indicates that they...

While China Education Group Holdings Limited ( HKG:839 ) might not have the largest market cap around , it received a...

China Conch Venture Holdings Limited ( HKG:586 ), might not be a large cap stock, but it saw significant share price...

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

The Alphamab Oncology ( HKG:9966 ) share price has softened a substantial 27% over the previous 30 days, handing back...

Shareholders appeared unconcerned with Sinopec Oilfield Service Corporation's ( HKG:1033 ) lackluster earnings report...

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...

The Comba Telecom Systems Holdings Limited ( HKG:2342 ) share price has softened a substantial 25% over the previous 30...

Key Insights The considerable ownership by individual investors in Sino-Ocean Group Holding indicates that they...

ASMPT (SEHK:522) drew attention today following its announcement of fourth-quarter revenue guidance that tops market consensus. Solid growth is expected both quarter-on-quarter and year-on-year, fueled by performance in both SEMI and SMT divisions. See our latest analysis for ASMPT. ASMPT shares have recently experienced some volatility, with a 7-day share price return of -6.4% as the market weighs its upbeat Q4 outlook alongside last quarter’s loss. Still, the stock’s 20.7% share price...

In recent weeks, global markets have experienced mixed performances, with the U.S. Federal Reserve cutting interest rates while major stock indices showed narrow gains driven by large-cap technology stocks. Amid these fluctuations and geopolitical developments like the U.S.-China trade truce, investors might find opportunities in stocks that appear undervalued compared to their intrinsic value, offering potential for growth as market conditions evolve.